← Home

What the research says

Drugs

Read-only from the Statory library · approved cards only · no estimates · exported 2026-11-04

224 cards · 44 from Korea · newest year first

  1. (Korean title)

    (Korean authors) · 2026 · South Korea

    (Korean)

    Country
    South Korea
    Design
    Other
    Licence
    Other
  2. (Korean title)

    (Korean authors) · 2026 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 15,842
    Design
    Meta-analysis
    Licence
    Other
  3. (Korean title)

    (Korean authors) · 2026 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 22
    Design
    Qualitative
    Licence
    Other
  4. (Korean title)

    (Korean authors) · 2026 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 42
    Design
    Cross-sectional
    Licence
    Other
  5. (Korean title)

    (Korean authors) · 2026 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 154
    Design
    Cross-sectional
    Licence
    Other
  6. (Korean title)

    (Korean authors) · 2026 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 198
    Design
    Cross-sectional
    Licence
    Other
  7. Follow-Up Patterns at a Low-Threshold Mobile Medical Unit Providing Opioid Use Disorder Care in an Urban Setting: A Group-Based Trajectory Modeling Approach

    Shah et al. · 2026 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 964
    Design
    Other
    Licence
    CC BY
  8. "This whole thing is relationship medicine": A qualitative analysis of mobile and street-delivered medication for opioid use disorder in King County, Washington, using RE-AIM

    Strong et al. · 2026 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 21
    Design
    Qualitative
    Licence
    CC BY
  9. Cannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice

    Alton et al. · 2026 · Country not stated

    CB1R and MOR mRNAs showed distinct regional distributions in mouse brain, with colocalization primarily in the paraventricular nucleus of the thalamus. In the PVT, ~50% of Vglut2-positive glutamatergic neurons displayed CB1R-MOR co-expression. Only 5%–25% of Vglut2-positive neurons in PAG and spinal dorsal horn, or Vgat-positive GABA neurons in NAc, VTA, and substantia nigra, showed colocalization. Selective MOR deletion from Vglut2+ or Vgat+ neurons did not alter Δ9-THC-induced analgesia, hypothermia, catalepsy, rotarod impairment, or conditioned place aversion. CB1R deletion from GABAergic neurons did not affect oxycodone-induced analgesia, hypothermia, or conditioned place preference.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  10. Effects of Alpha-Band Binaural Beat Entrainment on Anxiety and Aggression in Men With Opioid Use Disorder: A Randomized Sham-Controlled Trial

    Soleimanifar et al. · 2026 · Iran

    (Korean)

    Country
    Iran
    Sample
    n = 30
    Design
    Other
    Licence
    CC BY
  11. Clinical Profile and Risk Factors of Deliberate Self-Harm Among Patients Presenting to a Tertiary Care Hospital in Bangladesh

    Bhuiyan et al. · 2026 · Bangladesh

    Pesticide poisoning (39.2%) and drug overdose (31.7%) were the most common methods of deliberate self-harm. Vomiting (59.2%) and altered consciousness (28.3%) were the most frequent clinical features; 19.2% required ICU admission. Psychosocial stressors were present in 74.2%, psychiatric illness in 35.0%, and substance use in 30.0% of patients. Previous DSH was associated with psychiatric illness (68.0% vs 26.3%, p=0.001) and psychosocial factors (96.0% vs 68.4%, p=0.003). Substance use was associated with previous DSH (52.0% vs 24.2%, p=0.014); sex was not (p=0.118).

    Country
    Bangladesh
    Sample
    n = 120
    Design
    Cross-sectional
    Licence
    CC BY
  12. Buprenorphine initiation by a street medicine program is associated with reduced opioid-related emergency department utilization among people experiencing homelessness

    Wallace et al. · 2026 · United States

    (Korean)

    Country
    United States
    Sample
    n = 115
    Design
    Other
    Licence
    Other
  13. Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA

    Surratt et al. · 2026 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 33
    Design
    Qualitative
    Licence
    Other
  14. Treatment of opioid use disorder in pregnancy among individuals with and without co-occurring stimulant use disorder: A retrospective cohort study

    Charron et al. · 2026 · United States

    (Korean)

    Country
    United States
    Sample
    n = 1,206
    Design
    Other
    Licence
    Other
  15. (Korean title)

    (Korean authors) · 2026 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 7
    Design
    Qualitative
    Licence
    Other
  16. Fentanyl Education and Harm Reduction Developmental Program for Churches and Agencies in Norfolk, Virginia

    Miller · 2026 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    Other
  17. Economic analysis of a low-threshold mobile medical unit dispensing buprenorphine for opioid use disorder

    Shah et al. · 2026 · United States

    (Korean)

    Country
    United States
    Sample
    n = 30
    Design
    Cross-sectional
    Licence
    Other
  18. A qualitative study investigating the role of humor in supporting recovery from addiction

    Stull et al. · 2026 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 11
    Design
    Qualitative
    Licence
    Other
  19. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 22
    Design
    Qualitative
    Licence
    Other
  20. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 1,020
    Design
    Other
    Licence
    Other
  21. (Korean title)

    (Korean authors) · 2025 · South Korea

    Also covers · Tobacco

    (Korean)

    Country
    South Korea
    Sample
    n = 1,477
    Design
    Other
    Licence
    Other
  22. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 4
    Design
    Qualitative
    Licence
    Other
  23. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 4
    Design
    Qualitative
    Licence
    Other
  24. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 3
    Design
    Qualitative
    Licence
    Other
  25. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 9
    Design
    Qualitative
    Licence
    Other
  26. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Design
    Qualitative
    Licence
    Other
  27. Addressing the legal and health challenges of licensed medical cannabis users who want to travel abroad

    Bonny-Noach et al. · 2025 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 15
    Design
    Qualitative
    Licence
    CC BY
  28. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 3
    Design
    Qualitative
    Licence
    Other
  29. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 3
    Design
    Qualitative
    Licence
    Other
  30. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 19
    Design
    Qualitative
    Licence
    Other
  31. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 669
    Design
    Other
    Licence
    Other
  32. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Design
    Other
    Licence
    Other
  33. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 10
    Design
    Qualitative
    Licence
    Other
  34. (Korean title)

    (Korean authors) · 2025 · Canada

    (Korean)

    Country
    Canada
    Sample
    n = 3,406
    Design
    Other
    Licence
    Other
  35. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 50
    Design
    Other
    Licence
    Other
  36. The role of depression in the relationship between cannabis use and suicidal behaviours: A systematic review and meta-analysis

    Maviel et al. · 2025 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  37. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Design
    Cross-sectional
    Licence
    Other
  38. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 3
    Design
    Qualitative
    Licence
    Other
  39. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 10
    Design
    Qualitative
    Licence
    Other
  40. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 9
    Design
    Qualitative
    Licence
    Other
  41. (Korean title)

    (Korean authors) · 2025 · South Korea

    (Korean)

    Country
    South Korea
    Design
    Qualitative
    Licence
    Other
  42. (Korean title)

    (Korean authors) · 2024 · South Korea

    (Korean)

    Country
    South Korea
    Design
    Other
    Licence
    Other
  43. (Korean title)

    (Korean authors) · 2024 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 42
    Design
    Cross-sectional
    Licence
    Other
  44. (Korean title)

    (Korean authors) · 2024 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 30
    Design
    Other
    Licence
    Other
  45. (Korean title)

    (Korean authors) · 2024 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 19
    Design
    Cross-sectional
    Licence
    Other
  46. (Korean title)

    (Korean authors) · 2024 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 3
    Design
    Qualitative
    Licence
    Other
  47. Contextualizing medications for opioid use disorder and peer support service provision in the probation system with implementation science

    Kang et al. · 2024 · United States

    (Korean)

    Country
    United States
    Sample
    n = 10
    Design
    Qualitative
    Licence
    CC BY
  48. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators

    O’Grady et al. · 2024 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 46
    Design
    Qualitative
    Licence
    CC BY
  49. The relationship between felt stigma and non-fatal overdose among rural people who use drugs

    Sibley et al. · 2024 · United States

    (Korean)

    Country
    United States
    Sample
    n = 2,608
    Design
    Cross-sectional
    Licence
    CC BY
  50. Reviewing the Impact of Maternal Opioid Use Disorder on Fetal Development and Long-Term Pediatric Health Outcomes

    Asad et al. · 2024 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    CC BY
  51. Using alone at home: What's missing in housing-based responses to the overdose crisis?

    Fleming et al. · 2024 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    CC BY
  52. Stalled Scale-Up of Opioid Agonist Therapies for HIV Prevention in Kazakhstan: History, Policy, and Recommendations for Change

    Liberman et al. · 2024 · Kazakhstan

    (Korean)

    Country
    Kazakhstan
    Sample
    n = 95,000
    Design
    Other
    Licence
    CC BY
  53. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids

    Dahan et al. · 2024 · United States

    (Korean)

    Country
    United States
    Sample
    n = 1,000,000
    Design
    Other
    Licence
    CC BY
  54. (Korean title)

    (Korean authors) · 2024 · South Korea

    (Korean)

    Country
    South Korea
    Design
    Qualitative
    Licence
    Other
  55. (Korean title)

    (Korean authors) · 2024 · South Korea

    Also covers · Gaming

    (Korean)

    Country
    South Korea
    Sample
    n = 96
    Design
    Other
    Licence
    Other
  56. A systematic review and meta-analysis of neuromodulation therapies for substance use disorders

    Mehta et al. · 2024 · Country not stated

    rTMS reduced substance use and craving with medium to large effect sizes (Hedge's g > 0.5). Multiple stimulation sessions and left DLPFC targeting were most encouraging for rTMS. tDCS produced medium effect sizes for drug use and craving, though highly variable and less robust than rTMS. Right anodal DLPFC stimulation appeared most efficacious for tDCS. DBS studies were typically small and uncontrolled but showed promise in reducing misuse of multiple substances.

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  57. The Implementation of Drug Abuse Rehabilitation to Prevent Relapse: A Systematic Literature Review

    Erliyani et al. · 2024 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 27
    Design
    Meta-analysis
    Licence
    Other
  58. Intersectionality and Structural Drivers of Fatal Overdose Disparities in the United States: a Narrative Review

    Valasek et al. · 2023 · United States

    (Korean)

    Country
    United States
    Design
    Qualitative
    Licence
    CC BY
  59. Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences

    Matheson et al. · 2023 · Ireland

    Men have always been more likely to use cannabis than women, yet the sex/gender gap in prevalence has narrowed over time, possibly partly due to legalization. Women had lower odds (OR = 0.66) of favorable attitudes toward cannabis acceptability than men in 1,713 Canadian undergraduates. In 507 Irish adolescents, boys were more likely than girls to perceive cannabis as safe (OR = 2.02). Female gender was associated with lower odds of supporting cannabis legalization (OR = 0.46) in a Michigan survey of 2,190 adults. Evidence on sex/gender differences in legalization impacts on harms such as motor vehicle collisions and hospitalizations is more variable.

    Country
    Ireland
    Sample
    n = 2,190
    Design
    Other
    Licence
    CC BY
  60. Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia's invasion of Ukraine in five major cities in Ukraine

    Mazhnaya et al. · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 20
    Design
    Qualitative
    Licence
    CC BY
  61. Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

    (Korean authors) · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 40
    Design
    Other
    Licence
    CC BY
  62. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder

    Hua et al. · 2023 · United Kingdom

    (Korean)

    Country
    United Kingdom
    Sample
    n = 70
    Design
    Other
    Licence
    CC BY
  63. Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder

    Work et al. · 2023 · United States

    (Korean)

    Country
    United States
    Sample
    n = 26
    Design
    Qualitative
    Licence
    CC BY
  64. “I’m not going to lay back and watch somebody die”: a qualitative study of how people who use drugs’ naloxone experiences are shaped by rural risk environment and overdose education/naloxone distribution intervention

    Kesich et al. · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 29
    Design
    Qualitative
    Licence
    CC BY
  65. “As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids

    Frank et al. · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 32
    Design
    Qualitative
    Licence
    CC BY
  66. Biopsychosocial contexts of timely and adequate prenatal care utilization among women with criminal legal involvement and opioid use disorder

    Satcher et al. · 2023 · United States

    (Korean)

    Country
    United States
    Sample
    n = 317
    Design
    Cross-sectional
    Licence
    CC BY
  67. Health care and harm reduction provider perspectives on treating older adults who use non-medical opioids: a qualitative study set in Chicago

    Mason et al. · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 26
    Design
    Qualitative
    Licence
    CC BY
  68. Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol

    Crable et al. · 2023 · Country not stated

    Only 48.2% of adult Medicaid members and 4.7% of CHIP members living with opioid use disorder receive any evidence-based medications for opioid use disorder (MOUD). 18 state Medicaid agencies require prior authorizations for injectable naltrexone, while 39 agencies require prior authorization for oral buprenorphine. Nearly 36% of MCOs surveyed require prior authorization for MOUD, with MCOs differentially imposing these policies on access to buprenorphine, methadone, and naltrexone. Nearly 70% of all Medicaid members across the USA are enrolled in MCOs. Medicaid and CHIP provide health insurance benefits including 38% of individuals in the USA living with an opioid use disorder.

    Country
    Country not stated
    Design
    Cross-sectional
    Licence
    CC BY
  69. Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant

    Wouldes et al. · 2023 · United States

    (Korean)

    Country
    United States
    Sample
    n = 21,905
    Design
    Other
    Licence
    CC BY
  70. Responding to health policy recommendations on managing opioid use disorder during Russia's invasion of Ukraine: Divergent responses from the frontline to the west

    Ivasiy et al. · 2023 · Ukraine

    (Korean)

    Country
    Ukraine
    Sample
    n = 8
    Design
    Qualitative
    Licence
    CC BY
  71. Cannabis sativa: Applications of Artificial Intelligence (AI) and Plant Tissue Culture for Micropropagation

    Malabadi et al. · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    Other
  72. Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

    Zagorski et al. · 2023 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    CC BY
  73. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review

    McNair et al. · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 2,331
    Design
    Meta-analysis
    Licence
    CC BY
  74. (Korean title)

    (Korean authors) · 2023 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 4
    Design
    Qualitative
    Licence
    Other
  75. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians

    Booty et al. · 2023 · United States

    (Korean)

    Country
    United States
    Sample
    n = 25
    Design
    Qualitative
    Licence
    Other
  76. The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses

    Hill et al. · 2023 · Country not stated

    Cannabis is well established to impact affective states, emotion and perceptual processing, primarily through its interactions with the endocannabinoid system. Approximately 19% of individuals who use cannabis develop a cannabis use disorder (CUD). The few studies that have looked at therapeutic effect of cannabis itself have not found robust outcomes associated with cannabis. Inhibitors of endocannabinoid metabolism or modulators of cannabinoid receptor signaling have emerged as potential candidates for the treatment of psychiatric conditions. The current data available is quite promising and shows indications of several potential candidate diseases which may benefit from this approach.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  77. δ-opioid Receptor, Microglia and Neuroinflammation

    Xu et al. · 2023 · Country not stated

    Microglia are the major effector of neuroinflammation and account for 10% of total cerebral cells. DOR activation or overexpression protects neurons against hypoxic/ischemic and neurodegenerative injury via MAPKs, Nrf2 and PI3K/Akt pathways. DOR activation strongly protected neurons from hypoxia- and LPS-induced injury by inhibiting microglial pro-inflammatory transformation. Knocking-down DOR or restraining DOR activity promoted microglia activation and inflammatory events with aggravation of cell injury. Activated microglia can induce the A1 phenotype of astrocytes through secreting IL-1α, TNF-α, and C1q, further damaging neurons.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  78. (Korean title)

    (Korean authors) · 2023 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 9
    Design
    Qualitative
    Licence
    Other
  79. Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S.

    Krawczyk et al. · 2023 · United States

    (Korean)

    Country
    United States
    Sample
    n = 41
    Design
    Meta-analysis
    Licence
    Quote only
  80. Heroin and its metabolites: relevance to heroin use disorder

    Milella et al. · 2023 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    CC BY
  81. The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance

    Echeverria-Villalobos et al. · 2023 · Country not stated

    Activation of glial and immune cells increases production of proinflammatory mediators, creating a neuroinflammatory state. Neuroinflammation is a fundamental mechanism in the genesis of acute pain and its transition to neuropathic and chronic pain. Central sensitization, driven by microglial cytokines and chemokines, is crucial for chronification of acute pain. Activated immune and glial cells can disrupt opioid analgesic effects, contributing to tolerance, dependence, and paradoxical hyperalgesia. The incidence of pain persisting beyond wound healing after surgery is approximately 10%–85%, depending on the type of surgery.

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  82. Xylazine in the Opioid Epidemic: A Systematic Review of Case Reports and Clinical Implications

    Ayub et al. · 2023 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 59
    Design
    Meta-analysis
    Licence
    CC BY
  83. Non-opioid analgesics for the prevention of chronic postsurgical pain: a systematic review and network meta-analysis

    Doleman et al. · 2023 · Country not stated

    i.v. lidocaine (OR 0.32; 95% CrI 0.17–0.58) reduced the incidence of chronic postsurgical pain at ≤6 months. Ketamine (OR 0.64; 95% CrI 0.44–0.92) reduced the incidence of chronic postsurgical pain at ≤6 months. Gabapentinoids (OR 0.67; 95% CrI 0.47–0.92) reduced the incidence of chronic postsurgical pain at ≤6 months. Dexmedetomidine (OR 0.36; 95% CrI 0.12–1.00) possibly reduced the incidence of chronic postsurgical pain at ≤6 months. Little available evidence existed for chronic postsurgical pain at >6 months, combinations of agents, chronic opioid use, and serious adverse events.

    Country
    Country not stated
    Sample
    n = 23,902
    Design
    Meta-analysis
    Licence
    CC BY
  84. Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial

    Pashchenko et al. · 2022 · Ukraine

    (Korean)

    Country
    Ukraine
    Sample
    n = 818
    Design
    Other
    Licence
    CC BY
  85. Beliefs and misperceptions about naloxone and overdose among U.S. laypersons: a cross-sectional study

    Agley et al. · 2022 · United States

    (Korean)

    Country
    United States
    Sample
    n = 702
    Design
    Cross-sectional
    Licence
    CC BY
  86. Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study

    Cunningham et al. · 2022 · United States

    (Korean)

    Country
    United States
    Sample
    n = 4,858
    Design
    Cross-sectional
    Licence
    CC BY
  87. A measurement invariance analysis of selected Opioid Overdose Knowledge Scale (OOKS) items among bystanders and first responders

    Swartz et al. · 2022 · United States

    (Korean)

    Country
    United States
    Sample
    n = 1,795
    Design
    Cross-sectional
    Licence
    CC BY
  88. Methamphetamine Exposure in Adolescent Impairs Memory of Mice in Adulthood Accompanied by Changes in Neuroplasticity in the Dorsal Hippocampus

    Liang et al. · 2022 · China

    (Korean)

    Country
    China
    Sample
    n = 72
    Design
    Other
    Licence
    CC BY
  89. Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study

    Parkes et al. · 2022 · United Kingdom

    (Korean)

    Country
    United Kingdom
    Sample
    n = 68
    Design
    Other
    Licence
    CC BY
  90. Trend Analysis of Substance Use Disorder During Pregnancy

    Ndanga et al. · 2022 · United States

    (Korean)

    Country
    United States
    Sample
    n = 332,275
    Design
    Cross-sectional
    Licence
    CC BY
  91. Delivering transcutaneous auricular neurostimulation (tAN) to improve symptoms associated with opioid withdrawal: results from a prospective clinical trial

    Tirado et al. · 2022 · United States

    (Korean)

    Country
    United States
    Sample
    n = 31
    Design
    Other
    Licence
    CC BY
  92. Development of Goal Management Training+ for Methamphetamine Use Disorder Through Collaborative Design

    Anderson et al. · 2022 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Qualitative
    Licence
    CC BY
  93. The immediate and long-term effects of prenatal opioid exposure

    Yen et al. · 2022 · Country not stated

    Between 1999 and 2014, pregnant women with opioid use disorder increased from 1.5 to 6.5 cases per 1,000 hospital births, and NAS rose from 1.2 to 8.0 per 1,000 hospital births. Infants co-exposed to opioids and gabapentin had the highest absolute risk for severe NAS requiring pharmacologic treatment. Use of psychotropic medications in addition to prescription opioids increased NAS severity two-fold compared to prescription opioids alone. Infants randomized to 24 kcal/oz formula had greater weight gain than those receiving standard 20 kcal/oz formula. Punctate white matter lesions were reported in the brain of 8 of 20 opioid-exposed neonates.

    Country
    Country not stated
    Sample
    n = 20
    Design
    Other
    Licence
    CC BY
  94. Endogenous opioid systems alterations in pain and opioid use disorder

    Higginbotham et al. · 2022 · United States

    Endogenous opioid systems comprise four receptor families (MOPR, KOPR, DOPR, NOPR) acting through β-endorphins, dynorphins, enkephalins, and nociceptins to maintain homeostasis. Over half of US adults reported pain symptoms within the past 3 months (Lucas et al., 2021). Provisional estimates of opioid overdose deaths exceeded 80,000 in 2021 (Ahmad et al., 2022). Metanalyses suggest rates of problematic prescription opioid use may occur in >80% of pain patients. Among those who misused prescription opioids, the most common reason for misuse was to relieve physical pain (65%).

    Country
    United States
    Design
    Other
    Licence
    CC BY
  95. Current Status of Evidence for a New Diagnosis: Food Addiction-A Literature Review

    Vasiliu · 2022 · Country not stated

    A high prevalence of food addiction was found in the general population, up to 20% according to a meta-analytic research. The YFAS was constructed to match DSM IV criteria for substance dependence and validated for quantifying eating addiction severity. Reward dysfunction, impulsivity and emotion dysregulation have been considered basic mechanisms that trigger both eating dysfunctions and addictive behaviors. Genetic factors may be involved in this dependence, as modulators of higher carbohydrate and saturate fat craving. Lorcaserin, antiepileptic drugs, opioid antagonists, and antiaddictive agents may be intuitively used in food addiction, but clinical trials are necessary to confirm their efficacy.

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  96. Effectiveness of Interventions for Prevention of Common Infections Among Opioid Users: A Systematic Review of Systematic Reviews

    Puzhko et al. · 2022 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  97. Associations of employment status with opioid misuse: Evidence from a nationally representative survey in the U.S.

    Matthews et al. · 2022 · United States

    (Korean)

    Country
    United States
    Sample
    n = 40,143
    Design
    Cross-sectional
    Licence
    Other
  98. (Korean title)

    (Korean authors) · 2022 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    Other
  99. The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies

    Dalefield et al. · 2022 · Country not stated

    KOR agonists are potential alternatives to MOR agonists for pain due to anti-nociceptive effects, lack of abuse potential, and reduced respiratory depressive effects. Clinical use of KOR agonists is limited by adverse effects such as dysphoria, aversion, and sedation. G-protein biased KOR agonists may improve therapeutic index by avoiding β-arrestin-2-mediated dysphoric effects. Mixed opioid agonists like MP1104 produce anti-nociceptive effects without respiratory depression, conditioned place preference, or aversion in rodents. Peripherally restricted KOR agonists are being developed to reduce CNS-mediated side effects.

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  100. Opioids and Falls Risk in Older Adults: A Narrative Review

    Virnes et al. · 2022 · Netherlands

    (Korean)

    Country
    Netherlands
    Design
    Other
    Licence
    CC BY-NC
  101. Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials

    Lim et al. · 2022 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  102. (Korean title)

    (Korean authors) · 2021 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 1,873
    Design
    Cross-sectional
    Licence
    Other
  103. Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review

    Adams et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 24
    Design
    Meta-analysis
    Licence
    CC BY
  104. Illicitly Manufactured Fentanyl Entering the United States

    Pergolizzi et al. · 2021 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    CC BY
  105. Meeting the Needs of Families Involved in the Child Welfare System for Parental Substance Abuse: Outcomes From an Effectiveness Trial of the Families Actively Improving Relationships Program

    Saldana et al. · 2021 · United States

    (Korean)

    Country
    United States
    Sample
    n = 99
    Design
    Other
    Licence
    CC BY
  106. Can touch this: training to correct police officer beliefs about overdose from incidental contact with fentanyl

    Pozo et al. · 2021 · United States

    (Korean)

    Country
    United States
    Sample
    n = 204
    Design
    Other
    Licence
    CC BY
  107. Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome

    Jenkins et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 8
    Design
    Other
    Licence
    CC BY
  108. Cannabis and tobacco use prior to pregnancy and subsequent offspring birth outcomes: a 20-year intergenerational prospective cohort study

    Hines et al. · 2021 · Australia

    Also covers · Tobacco

    (Korean)

    Country
    Australia
    Sample
    n = 665
    Design
    Other
    Licence
    CC BY
  109. Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment

    Titus-Glover et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 12
    Design
    Qualitative
    Licence
    CC BY
  110. The elephant in the room; a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia

    Leiner et al. · 2021 · United States

    (Korean)

    Country
    United States
    Sample
    n = 27
    Design
    Qualitative
    Licence
    CC BY
  111. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment

    Campbell et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 170,000
    Design
    Other
    Licence
    CC BY
  112. The Vicious Cycle: Problematic Family Relations, Substance Abuse, and Crime in Adolescence: A Narrative Review

    Saladino et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 61
    Design
    Meta-analysis
    Licence
    CC BY
  113. Effects of Psychopathy on Neurocognitive Domains of Impulsivity in Abstinent Opiate and Stimulant Users

    Psederska et al. · 2021 · Bulgaria

    (Korean)

    Country
    Bulgaria
    Sample
    n = 693
    Design
    Cross-sectional
    Licence
    CC BY
  114. Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment

    Cole et al. · 2021 · United States

    (Korean)

    Country
    United States
    Sample
    n = 14
    Design
    Cross-sectional
    Licence
    CC BY
  115. The Role of Trauma in Early Onset Borderline Personality Disorder: A Biopsychosocial Perspective

    Bozzatello et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 766
    Design
    Meta-analysis
    Licence
    CC BY
  116. Cell-Type-Specific Adaptions in Striatal Medium-Sized Spiny Neurons and Their Roles in Behavioral Responses to Drugs of Abuse

    Allichon et al. · 2021 · Country not stated

    D1R-MSN and D2R-MSN form two largely segregated populations of striatal medium-sized spiny neurons expressing DA-D1 or DA-D2 receptors, respectively. About 5–15% of NAc MSN express both dopamine receptor subtypes depending on NAc subregions. Roughly half of NAc D1R-MSN has been shown to project in the ventral pallidum, the canonical output structure of indirect pathway MSN. Ablation, blockade, optogenetic inhibition or chemogenetic silencing of D1R-MSN tends to dampen behavioral adaptations to psychostimulants, while activation enhances these responses. Ablation or chemogenetic inhibition of D2R-MSN tends to enhance psychostimulant-evoked adaptations, while activation has opposite effects.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  117. Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review)

    Zhou et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    Quote only
  118. Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

    Palma-Álvarez et al. · 2021 · Spain

    (Korean)

    Country
    Spain
    Sample
    n = 126
    Design
    Cross-sectional
    Licence
    CC BY
  119. Public support for harm reduction: A population survey of Canadian adults

    Wild et al. · 2021 · Canada

    (Korean)

    Country
    Canada
    Sample
    n = 4,645
    Design
    Cross-sectional
    Licence
    CC BY
  120. Interaction of opioids with TLR4—mechanisms and ramifications

    Gabr et al. · 2021 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  121. Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence

    Nadeau et al. · 2021 · United States

    Estimated risk of death from opioid treatment involving doses above 100 MMED is approximately 0.25%/year. Prevalence of opioid use disorder associated with prescription opioids is likely less than 3%. Multiple large studies refute the concept that short-term opioid use for acute pain predisposes to opioid use disorder. In an EERW trial, 76.8% of completers achieved ≥30% pain reduction and 67.4% experienced >50% decrease in pain. Among participants, 53% were titrated to ≤90 MMED, 81% to ≤150 MMED, and 93% to ≤240 MMED.

    Country
    United States
    Sample
    n = 205
    Design
    Meta-analysis
    Licence
    CC BY
  122. Changes in opioid mortality following increased access to opioid substitution treatment

    Andersson et al. · 2020 · Sweden

    (Korean)

    Country
    Sweden
    Design
    Other
    Licence
    CC BY
  123. (Korean title)

    (Korean authors) · 2020 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 6,932,776
    Design
    Other
    Licence
    Other
  124. Community Care in Reach: Mobilizing Harm Reduction and Addiction Treatment Services for Vulnerable Populations

    Regis et al. · 2020 · United States

    (Korean)

    Country
    United States
    Sample
    n = 119
    Design
    Other
    Licence
    CC BY
  125. Female mice are more prone to develop an addictive-like phenotype for sugar consumption

    Wei et al. · 2020 · Germany

    (Korean)

    Country
    Germany
    Sample
    n = 83
    Design
    Other
    Licence
    CC BY
  126. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City

    Muncan et al. · 2020 · United States

    (Korean)

    Country
    United States
    Sample
    n = 32
    Design
    Qualitative
    Licence
    CC BY
  127. Training to reduce emergency responders' perceived overdose risk from contact with fentanyl: early evidence of success

    Winograd et al. · 2020 · United States

    (Korean)

    Country
    United States
    Sample
    n = 140
    Design
    Other
    Licence
    CC BY
  128. In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders

    Goodman et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 10
    Design
    Qualitative
    Licence
    CC BY
  129. Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors

    Escobar et al. · 2020 · Country not stated

    Acute activation of KOR decreases synaptic dopamine levels in the striatum, an effect shown by cerebral microdialysis in 1988. Direct infusion of the KOR antagonist nor-BNI increases basal dopamine levels in the NAc and dopamine release in the dorsal striatum. KOR knockout mice display increased extracellular dopamine levels in the striatum and NAc. Repeated KOR activation facilitates locomotor sensitization and compulsive checking behavior induced by repeated quinpirole administration. KOR blockade reverts dopaminergic changes in the dorsolateral striatum of amphetamine-sensitized rats without modifying their enhanced locomotor response to the drug.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  130. Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management

    Senese et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  131. Experiences of people taking opioid medication for chronic non-malignant pain: a qualitative evidence synthesis using meta-ethnography

    Nichols et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 31
    Design
    Meta-analysis
    Licence
    CC BY
  132. Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective

    Zhang et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  133. Dark Times: The Role of Negative Reinforcement in Methamphetamine Addiction

    May et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 400
    Design
    Meta-analysis
    Licence
    CC BY
  134. Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis

    Scuteri et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  135. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review

    Siefried et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 4,065
    Design
    Meta-analysis
    Licence
    Quote only
  136. Escalated Oxycodone Self-Administration and Punishment: Differential Expression of Opioid Receptors and Immediate Early Genes in the Rat Dorsal Striatum and Prefrontal Cortex

    Blackwood et al. · 2020 · Country not stated

    Footshocks separated oxycodone self-administering rats into shock-sensitive (n = 5) and shock-resistant (n = 6) phenotypes. Mu and Kappa opioid receptor proteins decreased significantly only in the dorsal striatum of all oxycodone self-administration rats. Delta opioid receptor protein was decreased in both the dorsal striatum and prefrontal cortex. c-fos, fosB, fra2, junB, egr1, and egr2 mRNAs decreased significantly in the dorsal striatum (but not PFC) of shock-sensitive rats. egr3 mRNA expression was increased in the PFC of only shock-resistant rats.

    Country
    Country not stated
    Sample
    n = 28
    Design
    Other
    Licence
    CC BY
  137. Retention of patients in opioid substitution treatment: A systematic review

    O'Connor et al. · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 294,592
    Design
    Meta-analysis
    Licence
    CC BY
  138. The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic

    Winstanley · 2020 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    Other
  139. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder

    Haffajee et al. · 2020 · United States

    (Korean)

    Country
    United States
    Sample
    n = 151
    Design
    Other
    Licence
    CC BY
  140. Financial incentives promote engagement in employment services for unemployed adults in treatment for opioid use disorder

    Holtyn et al. · 2020 · United States

    (Korean)

    Country
    United States
    Sample
    n = 91
    Design
    Other
    Licence
    Other
  141. (Korean title)

    (Korean authors) · 2020 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 9
    Design
    Qualitative
    Licence
    Other
  142. Sex Differences and the Role of Estradiol in Mesolimbic Reward Circuits and Vulnerability to Cocaine and Opiate Addiction

    Kokane et al. · 2020 · United States

    (Korean)

    Country
    United States
    Design
    Meta-analysis
    Licence
    CC BY
  143. (Korean title)

    (Korean authors) · 2019 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 5
    Design
    Qualitative
    Licence
    Other
  144. Predisposing and protective factors influencing suicide ideation, attempt, and death in patients accessing substance use treatment: a systematic review and meta-analysis protocol

    Espinet et al. · 2019 · United States

    (Korean)

    Country
    United States
    Sample
    n = 34,251
    Design
    Meta-analysis
    Licence
    CC BY
  145. Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails

    Ferguson et al. · 2019 · United States

    Monthly OUD prevalence in participating facilities ranged from 28 to 65% of the population. The proportion of individuals with OUD who received MAT ranged considerably from 9 to 61%. Only one site achieved sustained growth in the proportion of individuals treated over the course of the project. Facilitators included increased staffing and staff training, group education, data-driven change, justice coordination, and post-release contact. Barriers included lack of funding, space and institutional design, cultural perceptions of treatments, and inability to sustain care coordination at release.

    Country
    United States
    Sample
    n = 4
    Design
    Other
    Licence
    CC BY
  146. A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder

    Dennis et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 18
    Design
    Other
    Licence
    CC BY
  147. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco

    Carter et al. · 2019 · United States

    (Korean)

    Country
    United States
    Sample
    n = 95
    Design
    Other
    Licence
    CC BY
  148. Pain polymorphisms and opioids: An evidence based review

    Vieira et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    Quote only
  149. Chronic Pain and Chronic Opioid Use After Intensive Care Discharge – Is It Time to Change Practice?

    Stamenkovic et al. · 2019 · United Kingdom

    (Korean)

    Country
    United Kingdom
    Sample
    n = 575
    Design
    Meta-analysis
    Licence
    CC BY
  150. rTMS Reduces Psychopathological Burden and Cocaine Consumption in Treatment-Seeking Subjects With Cocaine Use Disorder: An Open Label, Feasibility Study

    Pettorruso et al. · 2019 · Italy

    (Korean)

    Country
    Italy
    Sample
    n = 20
    Design
    Other
    Licence
    CC BY
  151. Effects of Non-invasive Brain Stimulation on Stimulant Craving in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-Analysis

    Ma et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 321
    Design
    Meta-analysis
    Licence
    CC BY
  152. Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders

    Burns et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  153. Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits

    D'Souza · 2019 · Country not stated

    Also covers · Tobacco

    Psychostimulant drugs induce cognitive deficits including impulsivity, poor decision making, impaired cognitive flexibility, and deficits in learning and memory. These drug-induced cognitive deficits often impact adherence to addiction treatment programs and predispose abstinent addicts to drug use relapse. Psychostimulant addicts show high levels of both behavioral and decisional impulsivity than do healthy controls. In animals, repeated administration of cocaine, methamphetamine, and nicotine increased impulsive behavior. Recovering addicts with significant cognitive deficits are more vulnerable to relapse.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  154. Slow release oral morphine versus methadone for the treatment of opioid use disorder

    Klimas et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 471
    Design
    Meta-analysis
    Licence
    CC BY-NC
  155. A Survey of Molecular Imaging of Opioid Receptors

    Cumming et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  156. The search for the "next" euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning

    Sharma et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  157. Opioid Epidemic in the United States: Empirical Trends, and A Literature Review of Social Determinants and Epidemiological, Pain Management, and Treatment Patterns

    Singh et al. · 2019 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    Quote only
  158. Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

    Strang et al. · 2019 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    Quote only
  159. Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic

    Severino et al. · 2018 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    CC BY
  160. Employment services and substance abuse treatment

    Sherba et al. · 2018 · United States

    (Korean)

    Country
    United States
    Sample
    n = 800
    Design
    Other
    Licence
    Other
  161. Interaction Between Stress and Addiction: Contributions From Latin-American Neuroscience

    Torres-Berrio et al. · 2018 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  162. National trends and characteristics of inpatient detoxification for drug use disorders in the United States

    Zhu et al. · 2018 · United States

    (Korean)

    Country
    United States
    Sample
    n = 271,403
    Design
    Cross-sectional
    Licence
    CC BY
  163. The hot 'n' cold of cue-induced drug relapse

    Pitchers et al. · 2018 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Cross-sectional
    Licence
    CC BY-NC
  164. TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg

    Liu et al. · 2018 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  165. Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System

    Hauser et al. · 2018 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  166. The Association of Unfavorable Traffic Events and Cannabis Usage: A Meta-Analysis

    Hostiuc et al. · 2018 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  167. Vitamin B12 Levels in Methamphetamine Addicts

    Zhai et al. · 2018 · China

    Also covers · Tobacco

    (Korean)

    Country
    China
    Sample
    n = 231
    Design
    Cross-sectional
    Licence
    CC BY
  168. Lack of Effects of Extended Sessions of Transcranial Direct Current Stimulation (tDCS) Over Dorsolateral Prefrontal Cortex on Craving and Relapses in Crack-Cocaine Users

    Klauss et al. · 2018 · Brazil

    (Korean)

    Country
    Brazil
    Sample
    n = 35
    Design
    Other
    Licence
    CC BY
  169. GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia liability

    Pasman et al. · 2018 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 184,765
    Design
    Cross-sectional
    Licence
    Other
  170. Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo

    Ugur et al. · 2018 · Country not stated

    Native mu receptor heteromers were evidenced for delta, kappa, ORL1, CB1, Gal1, α2a, sst2, D1, CCR5, V1b, GRPR, and NMDA, using co-IP, electron microscopy, PLA, or interfering peptides. Mu-delta heteromerization induces cross-allosteric modulation with positive cooperativity, and co-application of subthreshold mu and delta agonists increased GABAergic inhibition in the RVM. Heteromers with non-opioid receptors such as Gal1 negatively modulate mu receptor G protein dependent signaling, with galanin dampening mu receptor signaling. Chronic morphine treatment enhances mu-delta heteromer density in brain regions associated with the reward pathway, with a concomitant mu-dependent increase in delta receptor surface localization. Expression of mu-α2a heteromers in the NTS is dynamically regulated and increased in hypertensive rats.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  171. Racial Bias in the US Opioid Epidemic: A Review of the History of Systemic Bias and Implications for Care

    Santoro et al. · 2018 · United States

    (Korean)

    Country
    United States
    Design
    Qualitative
    Licence
    CC BY
  172. Advances in Achieving Opioid Analgesia Without Side Effects

    Machelska et al. · 2018 · Country not stated

    Opioid actions are mediated by µ-, δ-, and κ-opioid receptors, which are G protein-coupled receptors. µ-receptor activation causes respiratory depression, sedation, constipation, nausea, vomiting, reward/euphoria, and dependence/withdrawal. δ-receptor activation can cause convulsions and may produce reward; κ-receptor agonists exert aversion/dysphoria, sedation, and diuresis. Peripheral opioid receptors mediate effective analgesia but are not involved in fatal effects in animal models and humans. β-arrestin-2 might be involved in morphine-induced analgesic tolerance, respiratory depression, and constipation.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  173. Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment

    Arnaudo et al. · 2017 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 531
    Design
    Meta-analysis
    Licence
    CC BY
  174. Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline

    Müller-Lissner et al. · 2017 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 33
    Design
    Meta-analysis
    Licence
    Quote only
  175. Review about gabapentin misuse, interactions, contraindications and side effects

    Quintero · 2017 · United Kingdom

    (Korean)

    Country
    United Kingdom
    Sample
    n = 1,500
    Design
    Meta-analysis
    Licence
    CC BY-NC
  176. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

    Sordo et al. · 2017 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 122,885
    Design
    Meta-analysis
    Licence
    Other
  177. Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs

    Lugoboni et al. · 2017 · Italy

    Also covers · Tobacco

    (Korean)

    Country
    Italy
    Sample
    n = 1,057
    Design
    Cross-sectional
    Licence
    Other
  178. Cannabis use, COMT, BDNF and age at first-episode psychosis

    Mané et al. · 2017 · Spain

    (Korean)

    Country
    Spain
    Sample
    n = 260
    Design
    Cross-sectional
    Licence
    Other
  179. ‘Spending My Own Money, Harming My Own Body’: Addiction Care in a Chinese Therapeutic Community

    Hyde · 2017 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Qualitative
    Licence
    Other
  180. Primary care models for treating opioid use disorders: What actually works? A systematic review

    Lagisetty et al. · 2017 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 35
    Design
    Meta-analysis
    Licence
    Quote only
  181. Is there room for resilience? A scoping review and critique of substance use literature and its utilization of the concept of resilience

    Rudzinski et al. · 2017 · Country not stated

    A total of 396 studies were retrieved; 319 were excluded and 77 were selected for providing a definition or operationalization of resilience. The majority of studies focus on youth and their resistance to, or engagement in, substance use. A small but growing area of research examines recovery from substance addiction as a form of resilience. Drug use is consistently presented as a 'risk factor' or 'maladaptive coping strategy' in the literature. Current conceptualizations of resilience are too narrow to recognize all potential manifestations of resilience practices in the daily lives of individuals who actively use drugs.

    Country
    Country not stated
    Sample
    n = 77
    Design
    Meta-analysis
    Licence
    CC BY
  182. Access to substance use treatment among young adults who use prescription opioids non-medically

    Liebling et al. · 2016 · United States

    (Korean)

    Country
    United States
    Sample
    n = 200
    Design
    Cross-sectional
    Licence
    CC BY
  183. MicroRNAs Modulate Interactions between Stress and Risk for Cocaine Addiction

    Doura et al. · 2016 · Country not stated

    Mice deficient in Ago2 in Drd2-expressing striatal neurons self-administer fewer cocaine infusions with a downward shift in the dose-response curve. Ago2-deficient mice show no preference for cocaine paired environments in conditioned place preference, unlike wild-type controls. Overexpression of miR-181a in the nucleus accumbens increases cocaine-induced conditioned place preference, whereas knockdown has the opposite effect. Overexpression of miR-124 in the nucleus accumbens attenuates cocaine conditioned place preference. miR-212 is upregulated 1.75-fold in dorsal striatum of rats with extended cocaine access; overexpression lowers cocaine self-administration.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  184. Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study

    Larochelle et al. · 2016 · United States

    (Korean)

    Country
    United States
    Sample
    n = 2,848
    Design
    Other
    Licence
    Other
  185. Neuroimmune Interaction in the Regulation of Peripheral Opioid-Mediated Analgesia in Inflammation

    Hua · 2016 · Country not stated

    Opioid receptors on peripheral sensory nerve terminals are activated by endogenous opioid peptides from immune cells, producing significant analgesia without central side effects. In early inflammation granulocytes (esp. neutrophils) are the major opioid-containing leukocyte; at later stages monocytes/macrophages and lymphocytes predominate. Inflammation increases opioid peptide expression and precursor mRNA in immune cells, with β-endorphin from pro-opiomelanocortin being the most prominent. Inflamed tissue shows increased metabolic breakdown of opioid peptides, suggesting release must occur close to peripheral opioid receptors. Opioid release from immune cells is calcium dependent, consistent with a regulated secretory vesicle pathway.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  186. Pharmacotherapy of Pain in the Older Population: The Place of Opioids

    Prostran et al. · 2016 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  187. Opioids and Viral Infections: A Double-Edged Sword

    Tahamtan et al. · 2016 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  188. Opioid Drugs in Patients With Liver Disease: A Systematic Review

    Soleimanpour et al. · 2016 · Country not stated

    In patients with liver disease, opioid analgesics should be administered cautiously, with lower doses at regular intervals based on signs of drug accumulation. Interactions of opioid drugs with different levels of substrates of the P450 cytochrome enzyme should be considered. Opioids should be used cautiously since they can cause sedation, constipation and sudden encephalopathy effects. Since clearance of these drugs in patients with hepatic insufficiency is decreased, the initial dose must be decreased and intervals between doses increased.

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  189. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden

    Richert et al. · 2015 · Sweden

    (Korean)

    Country
    Sweden
    Sample
    n = 27
    Design
    Qualitative
    Licence
    CC BY
  190. Methamphetamine and the hypothalamic-pituitary-adrenal axis

    Zuloaga et al. · 2015 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  191. Role of the endogenous cannabinoid system in nicotine addiction: novel insights

    Gamaleddin et al. · 2015 · Country not stated

    Also covers · Tobacco

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  192. Disruption of gut homeostasis by opioids accelerates HIV disease progression

    Meng et al. · 2015 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  193. Glutamatergic synaptic plasticity in the mesocorticolimbic system in addiction

    Huijstee et al. · 2015 · Country not stated

    Also covers · Tobacco

    A single in vivo cocaine exposure significantly increased the AMPAR/NMDAR ratio in VTA DA neurons, reflecting enhanced AMPAR and decreased NMDAR transmission. All addictive drugs tested (morphine, nicotine, benzodiazepines, ethanol) potentiated AMPAR transmission in VTA DA neurons 24 h after a single dose, whereas fluoxetine and carbamazepine did not. Cocaine-induced potentiation was present within 3 h, still observed after 5 days, but not after 10 days. Enhanced AMPAR transmission results from insertion of GluA2-lacking AMPARs, and the increased ratio also involves a GluN2B-to-GluN2A switch and GluN3A-containing NMDARs. Cocaine-induced plasticity was absent in D5 receptor knockout mice and in GluN3A knockout mice.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  194. Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction

    Chartoff et al. · 2015 · Country not stated

    Stress, anxiety, and depression are tightly linked to addiction, and whether they precede or result from compulsive drug use depends on many factors, including biological sex. KOR agonists produce signs of anxiety, fear, and depression in laboratory animals and humans, but these studies were almost exclusively conducted in males. Recent work from the authors' lab shows that female rats are less sensitive than males to the depressive-like effects of a KOR agonist (Russell et al., 2014). Drug-dependent women express greater negative emotional states such as stress and depression, and these are more likely to trigger craving and relapse in women than men. Women are twice as likely as men to suffer from anxiety and depression (Kessler, 2003).

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  195. The effects of adolescent methamphetamine exposure

    Buck et al. · 2015 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  196. (Korean title)

    (Korean authors) · 2015 · South Korea

    Also covers · Smartphone

    (Korean)

    Country
    South Korea
    Sample
    n = 7
    Design
    Qualitative
    Licence
    Other
  197. Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

    Butelman et al. · 2015 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  198. Opioid-induced hyperalgesia in chronic pain patients and the mitigating effects of gabapentin

    Stoicea et al. · 2015 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  199. Kir3 channel signaling complexes: focus on opioid receptor signaling

    Nagi et al. · 2014 · Country not stated

    Kir3.1/3.2 heterotetramers are considered prototypical neuronal channels, and Kir3 channel activation contributes to opioid analgesia in animal models. Mice with Kir3.2 insensitive to G protein activation showed reduced analgesic responses to morphine. Knock-out of Kir3.2 and 3.3 interfered with morphine's ability to prolong avoidance behavior in the hot plate test. Kir3.3 ablation was without effect on the analgesic response elicited by intrathecal morphine. Variations in KCNJ6 influence opioid dose requirements, while KCNJ3 variations showed no effect.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  200. The kappa opioid receptor: from addiction to depression, and back

    Lalanne et al. · 2014 · Country not stated

    Systemic administration of the KOR agonist U69593 or morphine yielded opposite effects, respectively producing CPA and CPP. KOR-induced CPA was abolished in DAT KOR-cKO mice, and restored upon virally mediated KOR re-expression in the VTA. Infusion of the KOR agonist U50,488H in the NAc was sufficient to induce a robust CPA. DA release in the NAc was decreased by infusion of a KOR agonist into the NAc, but not into the VTA. Infusion of a KOR antagonist (nor-BNI) into the NAc increased DA release.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  201. The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations

    Imani et al. · 2014 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY-NC
  202. Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review

    Kim et al. · 2014 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  203. Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis

    Dennis et al. · 2014 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  204. (Korean title)

    (Korean authors) · 2014 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 454
    Design
    Other
    Licence
    Other
  205. Kronic hysteria: Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm

    Bright et al. · 2013 · Australia

    (Korean)

    Country
    Australia
    Design
    Other
    Licence
    Quote only
  206. Executive cognitive dysfunction and ADHD in cocaine dependence: searching for a common cognitive endophenotype for addictive disorders

    Cunha et al. · 2013 · Brazil

    (Korean)

    Country
    Brazil
    Sample
    n = 101
    Design
    Cross-sectional
    Licence
    CC BY
  207. Positive youth development, life satisfaction, and problem behaviors of adolescents in intact and non-intact families in Hong Kong

    Shek et al. · 2013 · Hong Kong SAR China

    Also covers · Smartphone

    (Korean)

    Country
    Hong Kong SAR China
    Sample
    n = 3,328
    Design
    Cross-sectional
    Licence
    CC BY
  208. Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings

    Batalla et al. · 2013 · Country not stated

    142 studies were identified, of which 43 met the established criteria; 8 studies were in adolescent population. Morphological brain alterations were found in both adolescents and adults, particularly in medial temporal and frontal cortices, as well as the cerebellum. These structural effects may be related to the amount of cannabis exposure. Functional neuroimaging studies suggest different patterns of resting global and brain activity during several cognitive tasks in both adolescents and adults. These functional differences may indicate compensatory effects in response to chronic cannabis exposure.

    Country
    Country not stated
    Design
    Meta-analysis
    Licence
    CC BY
  209. Let-7 microRNAs and opioid tolerance

    He et al. · 2012 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY-NC
  210. Morphine and microRNA activity: is there a relation with addiction?

    Rodríguez · 2012 · Country not stated

    miR-let-7 acts as a mediator of the movement of the mu opioid receptor (MOR) mRNA into P-bodies, leading to translational repression. miR-23b links MOR expression and morphine treatment at the post-transcriptional level; long-term morphine treatment increases miR-23b expression in a dose- and time-dependent manner. Fentanyl increases NeuroD levels by reducing the amount of miR-190, but morphine does not affect the levels of NeuroD. Morphine treatment of monocytes led to a decrease in several anti-HIV miRNAs (mir-28, 125b, 150, and 382). Morphine modulates the expression of miR-133b and of its target transcript Pitx3, and morphine-induced regulation of miR-133b depends on ERK1/2 via zfMOR.

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  211. (Korean title)

    (Korean authors) · 2011 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 447
    Design
    Cross-sectional
    Licence
    Other
  212. Risky decision-making predicts short-term outcome of community but not residential treatment for opiate addiction. Implications for case management

    Passetti et al. · 2011 · United Kingdom

    (Korean)

    Country
    United Kingdom
    Sample
    n = 80
    Design
    Other
    Licence
    Other
  213. Anorexia Nervosa: A Unified Neurological Perspective

    Hasan et al. · 2011 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY-NC
  214. What can we learn from the Portuguese decriminalization of illicit drugs?

    Hughes et al. · 2010 · Portugal

    (Korean)

    Country
    Portugal
    Sample
    n = 13
    Design
    Other
    Licence
    Other
  215. Cocaine- and Amphetamine-Regulated Transcript (CART) Signaling within the Paraventricular Thalamus Modulates Cocaine-Seeking Behaviour

    James et al. · 2010 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  216. Illicit drug use and problematic use in the elderly: is there a case for concern?

    Shah et al. · 2008 · United States

    (Korean)

    Country
    United States
    Design
    Other
    Licence
    Quote only
  217. Ethanol/Naltrexone Interactions at the mu-Opioid Receptor. CLSM/FCS Study in Live Cells

    Vukojević et al. · 2008 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    CC BY
  218. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation

    Connock et al. · 2007 · United Kingdom

    (Korean)

    Country
    United Kingdom
    Design
    Meta-analysis
    Licence
    Quote only
  219. The mental health risks of adolescent cannabis use

    Hall · 2006 · Sweden

    (Korean)

    Country
    Sweden
    Sample
    n = 50,465
    Design
    Other
    Licence
    CC BY
  220. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users

    Shannon et al. · 2006 · Canada

    Also covers · Tobacco

    Recent injection drug use was independently associated with willingness to use a SSF (OR = 1.72, 95% CI: 1.09–2.70). Having equipment confiscated or broken by police was associated with willingness to use a SSF (OR = 1.96, 95% CI: 1.24–2.85). Crack bingeing (OR = 2.16, 95% CI: 1.39–3.12) and smoking crack in public places (OR = 2.48, 95% CI: 1.65–3.27) were associated with willingness. Borrowing crack pipes (OR = 2.50, 95% CI: 1.86–3.40) and burns/inhaled brillo due to rushing smoke in public places (OR = 4.37, 95% CI: 2.71–8.64) were associated with willingness.

    Country
    Canada
    Sample
    n = 437
    Design
    Cross-sectional
    Licence
    CC BY
  221. (Korean title)

    Lyoo et al. · 2005 · South Korea

    (Korean)

    Country
    South Korea
    Sample
    n = 49
    Design
    Cross-sectional
    Licence
    Other
  222. Efficacy of acupuncture for cocaine dependence: a systematic review & meta-analysis

    Mills et al. · 2005 · United States

    (Korean)

    Country
    United States
    Sample
    n = 1,747
    Design
    Meta-analysis
    Licence
    CC BY
  223. Effectiveness of Substance Abuse Treatment Programming for Women: A Review

    Ashley et al. · 2003 · Country not stated

    (Korean)

    Country
    Country not stated
    Sample
    n = 38
    Design
    Meta-analysis
    Licence
    Other
  224. Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice

    Stein et al. · 2002 · Country not stated

    (Korean)

    Country
    Country not stated
    Design
    Other
    Licence
    Quote only